We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Advanced UTI Testing Solution Reduces Health Care Costs, Utilization and Antibiotic Resistance

By LabMedica International staff writers
Posted on 21 Jun 2023

Urinary Tract Infections (UTIs) result in a significant number of doctor appointments and emergency room visits every year, causing a significant global healthcare burden. More...

Although some people can easily detect and treat infections with medical help, others suffering from recurrent or complicated UTIs often struggle, undergoing numerous antibiotic treatments. In these cases, or those involving high-risk individuals, promptly identifying and treating the infection before it progresses is crucial. Now, an innovative testing solution addresses this health issue by aiding doctors in selecting the most effective treatment plan for each patient, expediting the right treatment, and reducing UTI-related hospital visits and admissions.

Pathnostics’ (Irvine, CA, USA) Guidance UTI is an advanced diagnostic testing solution designed for the rapid identification and accurate treatment of recurrent, complicated, and persistent UTIs, particularly in high-risk patients. The test can identify recognized uropathogens and antibiotic resistance genes and employs a unique Pooled Antibiotic Susceptibility Testing (P-AST) technology. This provides personalized data on antibiotic sensitivity and resistance and is particularly adept at addressing polymicrobial infections that can affect antibiotic resistance due to bacterial interactions.

Contrary to standard urine cultures that can take 3-5 days and often produce numerous false negatives, Guidance UTI can identify specific uropathogens, even in cases of multiple organism presence, in less than a day from samples received at the lab. Moreover, it can identify potential treatment options to quickly manage polymicrobial infections, providing advanced data in situations where traditional treatment methods pose challenges. Real-world evidence has demonstrated that the Guidance UTI test is associated with decreased adverse outcomes, healthcare resource usage, and costs for complicated UTIs when compared to standard urine culture.

"UTIs place a significant burden on individuals' health, as well as our health care system and resources. When they are not effectively treated, complications can lead to substantial medical issues and expenses," said David Pauluzzi, CEO and co-founder, Pathnostics. "These new findings, combined with ongoing studies, support our mission of increasing access to advanced UTI testing that supports more informed treatment leading to improved outcomes."

Related Links:
Pathnostics 


Gold Member
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Collection and Transport System
PurSafe Plus®
New
Silver Member
PCR Plates
Diamond Shell PCR Plates
New
8-Channel Pipette
SAPPHIRE 20–300 µL
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Molecular Diagnostics

view channel
Image: The study has linked blood proteins to Alzheimer’s disease and memory loss (Photo courtesy of Shutterstock)

Blood Test Could Detect Proteins Linked to Alzheimer's Disease and Memory Loss

Alzheimer’s disease has long been associated with sticky amyloid plaques in the brain, but these markers alone do not fully explain the memory loss and cognitive decline patients experience.... Read more

Hematology

view channel
Image: New research points to protecting blood during radiation therapy (Photo courtesy of 123RF)

Pioneering Model Measures Radiation Exposure in Blood for Precise Cancer Treatments

Scientists have long focused on protecting organs near tumors during radiotherapy, but blood — a vital, circulating tissue — has largely been excluded from dose calculations. Each blood cell passing through... Read more

Pathology

view channel
Image: An adult fibrosarcoma case report has shown the importance of early diagnosis and targeted therapy (Photo courtesy of Sultana and Sailaja/Oncoscience)

Accurate Pathological Analysis Improves Treatment Outcomes for Adult Fibrosarcoma

Adult fibrosarcoma is a rare and highly aggressive malignancy that develops in connective tissue and often affects the limbs, trunk, or head and neck region. Diagnosis is complex because tumors can mimic... Read more

Technology

view channel
Image: Conceptual design of the CORAL capsule for microbial sampling in the small intestine (H. Mohammed et al., Device (2025). DOI: 10.1016/j.device.2025.100904)

Coral-Inspired Capsule Samples Hidden Bacteria from Small Intestine

The gut microbiome has been linked to conditions ranging from immune disorders to mental health, yet conventional stool tests often fail to capture bacterial populations in the small intestine.... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.